Understand Why Semglee Will Be “Interchangeable” With Lantus

September 2021

Semglee (insulin glargine-yfgn U-100) will be the first “interchangeable” biosimilar.

It was originally approved as a new brand of insulin glargine, not a Lantus generic...and switching required a new Rx. Now that’s changing.

Be aware of what an “interchangeable” biosimilar is.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

COVID-19 Know When to Offer COVID-19 Post-Exposure Prophylaxis
Vaginal Infections Save Brexafemme and Solosec as a Last Resort for Vaginal Infections
Statins Continue to Avoid Routine Statin Use in Pregnancy
Biosimilars Understand Why Semglee Will Be “Interchangeable” With Lantus
Fever Give Advice on Treating Fever in Children
Diabetes Have a Plan to Manage Diabetes Meds During a Fast
Hypertension Individualize Treatment for Resistant Hypertension
Infections Treat Foot Infections in Diabetes Based on Severity
ADHD Know How New Stimulant and Nonstimulant ADHD Meds Compare
Poisoning Know When High Acetylcysteine Doses May Be Used
Pumps Help Patients Admitted With a Pump
Cannabinoids Be Ready to Treat Cannabinoid Hyperemesis Syndrome